Clinical and echocardiographic outcomes of the first 500 patients in the Align-AR trial for pure AR

1 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Jonathan Curio interviews Raj Makkar about the results of the Align-AR trial which he presented during the ACC.25 in Chicago.
The ALIGN-AR trial found the Trilogy valve safe and effective for aortic regurgitation, with high survival, strong device success, and improved heart function. These promising results will lead to further research, including expansion to lower-risk patients.

More info about the ACC 2025 Late Breaking Clinical Trials covered by PCRonline: https://www.pcronline.com/News/Whats-new-on-PCRonline/2025/ACC/PCR-ACC-Scientific-Sessions

#TAVI #ACC25
Category
Cardiology
Be the first to comment

Up Next